Condition
Vulvar Disease
Total Trials
2
Recruiting
0
Active
0
Completed
1
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Treatment Research
1 treatments under study, led by Topical Lidocaine Oral Desipramine Andor Placebo
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 100/100
Termination Rate
50.0%
1 terminated out of 2 trials
Success Rate
50.0%
-36.6% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed1
Terminated1
Trial Success Rate
50.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Topical Lidocaine Oral Desipramine Andor Placebo1
Active Sponsors
- University of Rochester1
- Northwestern University1
Top Investigators
University of Rochester
Northwestern University
Related Conditions
- Lichen Planus1
- Lichen Sclerosus1
- Vulvodynia1